Invention Grant
- Patent Title: Treatment of renal cell carcinoma
- Patent Title (中): 肾细胞癌的治疗
-
Application No.: US13200222Application Date: 2011-09-21
-
Publication No.: US08349823B2Publication Date: 2013-01-08
- Inventor: Börje Haraldsson , Ulf Nilsson , Lisa Buvall , Jenny Nyström
- Applicant: Börje Haraldsson , Ulf Nilsson , Lisa Buvall , Jenny Nyström
- Applicant Address: SE Gothenburg
- Assignee: Oncorena AB
- Current Assignee: Oncorena AB
- Current Assignee Address: SE Gothenburg
- Agent Lynn E. Barber
- Main IPC: A61K31/33
- IPC: A61K31/33
Abstract:
Methods are provided of treating renal cancer by administration of certain 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide compounds, especially 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided.
Public/Granted literature
- US20120077846A1 Treatment of renal cell carcinoma Public/Granted day:2012-03-29
Information query
